Skip navigation
Search
Sciety application settings
Home
Groups
Explore
Newsletter
About
Log In
Sign Up
Understanding tumour growth variability in breast cancer xenograft models identifies PARP inhibition resistance biomarkers
D. Voulgarelis
J. V. Forment
A. Herencia Ropero
D. Polychronopoulos
J. Cohen-Setton
A. Bender
V. Serra
M. J. O’Connor
J. W. T. Yates
K. C. Bulusu
Read the full article
See related articles
Listed in
This article is not in any list yet, why not save it to one of your lists.
Log in to save this article
Abstract
No abstract available
Article activity feed
Version published to 10.1038/s41698-024-00702-x
Nov 18, 2024
Version published to 10.21203/rs.3.rs-3893834/v1 on Research Square
Feb 13, 2024
Related articles
Modelling oxaliplatin resistance in colorectal cancer reveals a
SERPINE1
-based gene signature (RESIST-M) and therapeutic strategies for pro-metastatic CMS4 subtype
This article has 18 authors:
Stephen Qi Rong Wong
Mohua Das
Niranjan Shirgaonkar
Kenzom Tenzin
Huiwen Chua
Lin Xuan Chee
Sae Yeoh Ahpa
Astley Aruna Murugiah
Wei Yong Chua
Madelaine Skolastika Theardy
Matan Thangavelu Thangavelu
Jane Vin Chan
Choon Kong Yap
Iain Bee Huat Tan
Petros Tsantoulis
Sabine Tejpar
Jia Min Loo
Ramanuj Dasgupta
Identifying potential therapeutic targets for prostate cancer with mediating role in tumor immunity
This article has 5 authors:
Zhechun Wu
Sihan Li
Yuqing Li
Zhizhi Wang
Wei Wang
S100A9 Promotes Resistance to Anti-PD-1 Immunotherapy in Hepatocellular Carcinoma by Degrading PARP1 and Activating the STAT3/PD-L1 Pathway
This article has 14 authors:
Xianwei Zhou
Chu Qiao
Xuehui Chu
Haoran Man
Jingxin Liu
Yunzheng Li
Huan Li
Xiaodong Shan
Weihong Wang
Zaowu Lian
Yanjun Lu
Decai Yu
Xitai Sun
Binghua Li
Site navigation links
Home
Groups
Explore
Newsletter
About
Log In
Sign Up